| Noah S Siegel, MD | |
|
800 Huntington Ave, Boston, MA 02115-6303 | |
| (617) 936-6160 | |
| Not Available |
| Full Name | Noah S Siegel |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 29 Years |
| Location | 800 Huntington Ave, Boston, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861506776 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 204511 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Massachusetts Eye And Ear Infirmary - | Boston, MA | Hospital |
| Sturdy Memorial Hospital | Attleboro, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Massachusetts Eye And Ear Associates, Inc | 4486540275 | 337 |
| Sturdy Memorial Hospital Inc | 4981653789 | 42 |
News Archive
For most of the day, Graciela Del Angel felt shortness of breath and a tightness in her chest. Though her symptoms were uncomfortable, they became unbearable about midnight. By then, she had difficulty breathing and deep chest pains—all signs of a heart attack.
Thyroid carcinoma is the third most common tumor malignancy in children. This pediatric cancer shares several characteristics with adult thyroid cancer patients including common cellular subtypes that are papillary, follicular and medullary; a female to male ratio is approximately 6:1; and a cervical nodal disease that can be observed at the time of presentation in 30-60 percent in both papillary and follicular malignancies.
Micromet, Inc., today announced the publication of pre-clinical data in the Proceedings of the National Academy of Sciences, demonstrating the potency of new product candidates based on the Company's proprietary BiTE antibody technology. BiTE antibodies are a new class of agents designed to harness a patient's T cells to kill cancer cells.
"Tobacco use led to almost six million deaths in 2011, according to new research released ... on Monday, of which nearly 80 percent were in low- and middle-income countries," Inter Press Service reports.
› Verified 2 days ago
| Entity Name | Massachusetts Eye And Ear Associates, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932574332 PECOS PAC ID: 4486540275 Enrollment ID: O20040227000123 |
News Archive
For most of the day, Graciela Del Angel felt shortness of breath and a tightness in her chest. Though her symptoms were uncomfortable, they became unbearable about midnight. By then, she had difficulty breathing and deep chest pains—all signs of a heart attack.
Thyroid carcinoma is the third most common tumor malignancy in children. This pediatric cancer shares several characteristics with adult thyroid cancer patients including common cellular subtypes that are papillary, follicular and medullary; a female to male ratio is approximately 6:1; and a cervical nodal disease that can be observed at the time of presentation in 30-60 percent in both papillary and follicular malignancies.
Micromet, Inc., today announced the publication of pre-clinical data in the Proceedings of the National Academy of Sciences, demonstrating the potency of new product candidates based on the Company's proprietary BiTE antibody technology. BiTE antibodies are a new class of agents designed to harness a patient's T cells to kill cancer cells.
"Tobacco use led to almost six million deaths in 2011, according to new research released ... on Monday, of which nearly 80 percent were in low- and middle-income countries," Inter Press Service reports.
› Verified 2 days ago
| Entity Name | Sturdy Memorial Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730106162 PECOS PAC ID: 4981653789 Enrollment ID: O20050119000678 |
News Archive
For most of the day, Graciela Del Angel felt shortness of breath and a tightness in her chest. Though her symptoms were uncomfortable, they became unbearable about midnight. By then, she had difficulty breathing and deep chest pains—all signs of a heart attack.
Thyroid carcinoma is the third most common tumor malignancy in children. This pediatric cancer shares several characteristics with adult thyroid cancer patients including common cellular subtypes that are papillary, follicular and medullary; a female to male ratio is approximately 6:1; and a cervical nodal disease that can be observed at the time of presentation in 30-60 percent in both papillary and follicular malignancies.
Micromet, Inc., today announced the publication of pre-clinical data in the Proceedings of the National Academy of Sciences, demonstrating the potency of new product candidates based on the Company's proprietary BiTE antibody technology. BiTE antibodies are a new class of agents designed to harness a patient's T cells to kill cancer cells.
"Tobacco use led to almost six million deaths in 2011, according to new research released ... on Monday, of which nearly 80 percent were in low- and middle-income countries," Inter Press Service reports.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Noah S Siegel, MD 800 Huntington Ave, Boston, MA 02115-6303 Ph: (617) 936-6160 | Noah S Siegel, MD 800 Huntington Ave, Boston, MA 02115-6303 Ph: (617) 936-6160 |
News Archive
For most of the day, Graciela Del Angel felt shortness of breath and a tightness in her chest. Though her symptoms were uncomfortable, they became unbearable about midnight. By then, she had difficulty breathing and deep chest pains—all signs of a heart attack.
Thyroid carcinoma is the third most common tumor malignancy in children. This pediatric cancer shares several characteristics with adult thyroid cancer patients including common cellular subtypes that are papillary, follicular and medullary; a female to male ratio is approximately 6:1; and a cervical nodal disease that can be observed at the time of presentation in 30-60 percent in both papillary and follicular malignancies.
Micromet, Inc., today announced the publication of pre-clinical data in the Proceedings of the National Academy of Sciences, demonstrating the potency of new product candidates based on the Company's proprietary BiTE antibody technology. BiTE antibodies are a new class of agents designed to harness a patient's T cells to kill cancer cells.
"Tobacco use led to almost six million deaths in 2011, according to new research released ... on Monday, of which nearly 80 percent were in low- and middle-income countries," Inter Press Service reports.
› Verified 2 days ago
Dr. Steven D. Rauch, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 243 Charles St, Boston, MA 02114 Phone: 617-523-7900 | |
Elliott D. Kozin, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 243 Charles St, Boston, MA 02114 Phone: 617-573-6545 | |
Katherine Nicole Vandenberg, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 830 Harrison Ave Ste 1400, Boston, MA 02118 Phone: 617-638-8124 | |
Yoon Sun Chun, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 75 Francis St, Brigham And Women's Hospital Dept Of Plastic Surgery, Boston, MA 02115 Phone: 617-732-8181 Fax: 617-983-4534 | |
Jaimie Derosa, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 91 Newbury St, Suite 300, Boston, MA 02116 Phone: 617-262-8000 Fax: 617-262-8002 | |
Dr. Usama M Aboelkheir, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 736 Cambridge St, Smc8, Boston, MA 02135 Phone: 617-789-5004 Fax: 617-779-6481 | |
Phillip C Song, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 243 Charles St, Boston, MA 02114 Phone: 617-573-3557 |